Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunopathogenesis and therapy of cutaneous T cell lymphoma
Ellen J. Kim, Stephen D. Hess, Stephen K. Richardson, et al.
Journal of Clinical Investigation (2005) Vol. 115, Iss. 4, pp. 798-812
Open Access | Times Cited: 400

Showing 1-25 of 400 citing articles:

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
Richard Piekarz, Robin Frye, Maria L. Turner, et al.
Journal of Clinical Oncology (2009) Vol. 27, Iss. 32, pp. 5410-5417
Open Access | Times Cited: 712
Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors
James J. Campbell, Rachael A. Clark, Rei Watanabe, et al.
Blood (2010) Vol. 116, Iss. 5, pp. 767-771
Open Access | Times Cited: 484
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
Franz Trautinger, Robert Knobler, Rein Willemze, et al.
European Journal of Cancer (2006) Vol. 42, Iss. 8, pp. 1014-1030
Closed Access | Times Cited: 408
Vorinostat
Steven Grant, Chris Easley, Peter J. Kirkpatrick
Nature Reviews Drug Discovery (2006) Vol. 6, Iss. 1, pp. 21-22
Closed Access | Times Cited: 384
Genomic landscape of cutaneous T cell lymphoma
Jaehyuk Choi, Gerald Goh, Trent Walradt, et al.
Nature Genetics (2015) Vol. 47, Iss. 9, pp. 1011-1019
Open Access | Times Cited: 384
CCR4 and its ligands: from bench to bedside
Osamu Yoshie, Kouji Matsushima
International Immunology (2014) Vol. 27, Iss. 1, pp. 11-20
Open Access | Times Cited: 360
Non-Hodgkin’s Lymphomas
Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani, et al.
Journal of the National Comprehensive Cancer Network (2010) Vol. 8, Iss. 3, pp. 288-334
Open Access | Times Cited: 338
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
Madeleine Duvic, Jenny Vu
Expert Opinion on Investigational Drugs (2007) Vol. 16, Iss. 7, pp. 1111-1120
Closed Access | Times Cited: 325
Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
Leigh Ellis, Yan Pan, Gordon K. Smyth, et al.
Clinical Cancer Research (2008) Vol. 14, Iss. 14, pp. 4500-4510
Open Access | Times Cited: 297
Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes
Linghua Wang, Xiao Ni, Kyle Covington, et al.
Nature Genetics (2015) Vol. 47, Iss. 12, pp. 1426-1434
Open Access | Times Cited: 296
Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
Karen M. VanderMolen, William McCulloch, Cedric J. Pearce, et al.
The Journal of Antibiotics (2011) Vol. 64, Iss. 8, pp. 525-531
Open Access | Times Cited: 279
How I treat mycosis fungoides and Sézary syndrome
Sean Whittaker, Richard T. Hoppe, H. Miles Prince
Blood (2016) Vol. 127, Iss. 25, pp. 3142-3153
Open Access | Times Cited: 229
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma
Alain H. Rook, Joel M. Gelfand, Maria Wysocka, et al.
Blood (2015) Vol. 126, Iss. 12, pp. 1452-1461
Open Access | Times Cited: 197
The Risk of Lymphoma in Patients with Psoriasis
Joel M. Gelfand, Daniel B. Shin, Andrea L. Neimann, et al.
Journal of Investigative Dermatology (2006) Vol. 126, Iss. 10, pp. 2194-2201
Open Access | Times Cited: 306
Mycosis fungoides and Sézary syndrome
Samuel Hwang, John E. Janik, Elaine S. Jaffe, et al.
The Lancet (2008) Vol. 371, Iss. 9616, pp. 945-957
Closed Access | Times Cited: 267
Selective Induction of Apoptosis by Histone Deacetylase Inhibitor SAHA in Cutaneous T-Cell Lymphoma Cells: Relevance to Mechanism of Therapeutic Action
Chunlei Zhang, Victoria M. Richon, Xiao Ni, et al.
Journal of Investigative Dermatology (2005) Vol. 125, Iss. 5, pp. 1045-1052
Open Access | Times Cited: 245
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
Youn H. Kim, Dita Gratzinger, Cameron Harrison, et al.
Blood (2011) Vol. 119, Iss. 2, pp. 355-363
Open Access | Times Cited: 206
Down-regulating constitutive activation of the NF-κB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis
Aurore Sors, Francette Jean-Louis, C Pellet, et al.
Blood (2005) Vol. 107, Iss. 6, pp. 2354-2363
Open Access | Times Cited: 171
TH2 Cytokines from Malignant Cells Suppress TH1 Responses and Enforce a Global TH2 Bias in Leukemic Cutaneous T-cell Lymphoma
Emmanuella Guenova, Rei Watanabe, Jessica E. Teague, et al.
Clinical Cancer Research (2013) Vol. 19, Iss. 14, pp. 3755-3763
Open Access | Times Cited: 170
Constitutive Activation of Signal Transducers and Activators of Transcription Predicts Vorinostat Resistance in Cutaneous T-Cell Lymphoma
Valeria R. Fantin, Andrey Loboda, Cloud P. Paweletz, et al.
Cancer Research (2008) Vol. 68, Iss. 10, pp. 3785-3794
Open Access | Times Cited: 168
Total Skin Electron Beam and Non-Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation in Advanced Mycosis Fungoides and Sézary Syndrome
Madeleine Duvic, Michèle L. Donato, Bouthaina S. Dabaja, et al.
Journal of Clinical Oncology (2010) Vol. 28, Iss. 14, pp. 2365-2372
Open Access | Times Cited: 162
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
Elise A. Olsen, Alain H. Rook, John A. Zic, et al.
Journal of the American Academy of Dermatology (2010) Vol. 64, Iss. 2, pp. 352-404
Closed Access | Times Cited: 161
The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas
Ines Garces de los Fayos Alonso, Huan-Chang Liang, Suzanne D. Turner, et al.
Cancers (2018) Vol. 10, Iss. 4, pp. 93-93
Open Access | Times Cited: 153
Vitamin D and the Skin: An Update for Dermatologists
Elio Kechichian, Khaled Ezzedine
American Journal of Clinical Dermatology (2017) Vol. 19, Iss. 2, pp. 223-235
Closed Access | Times Cited: 151
Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation
Larisa J. Geskin, Sara Viragova, Donna B. Stolz, et al.
Blood (2015) Vol. 125, Iss. 18, pp. 2798-2805
Open Access | Times Cited: 141
Page 1 - Next Page

Scroll to top